Reference

1. Lee Y, Gustafsson ÅB. Role of apoptosis in cardiovascular disease. Apoptosis. 2009 Apr;14:536-48.
2. Lobo RO, Sagar BC, Shenoy CK. Bio-tea prevents membrane destabilization during isoproterenol-induced myocardial injury. Journal of microscopy and ultrastructure. 2017 Sep 1;5(3):146-54.
3. Eltobshy SA, Hussein AM, Elmileegy AA, Askar MH, Khater Y, Metias EF, Helal GM. Effects of heme oxygenase-1 upregulation on isoproterenol-induced myocardial infarction. The Korean Journal of Physiology & Pharmacology. 2019 May 1;23(3):203-17.
4. Bloom S, Davis DL. Calcium as mediator of isoproterenol-induced myocardial necrosis. The American journal of pathology. 1972 Dec;69(3):459.
5. Rona G. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch pathol. 1959;67:443-55.
6. Kagan VE, Serbinova EA, Forte T, Scita G, Packer L. Recycling of vitamin E in human low density lipoproteins. Journal of Lipid Research. 1992 Mar 1;33(3):385-97.
7. Yogeeta SK, Hanumantra RB, Gnanapragasam A, Subramanian S, Rajakannu S, Devaki T. Attenuation of abnormalities in the lipid metabolism during experimental myocardial infarction induced by isoproterenol in rats: beneficial effect of ferulic acid and ascorbic acid. Basic & clinical pharmacology & toxicology. 2006 May;98(5):467-72.
8. Punithavathi VR, Prince PS. Combined effects of quercetin and ?-tocopherol on lipids and glycoprotein components in isoproterenol induced myocardial infarcted Wistar rats. Chemico-Biological Interactions. 2009 Oct 30;181(3):322-7.
9. Mostafavi–Pour Z, Zal F, Monabati A, Vessal M. Protective effects of a combination of quercetin and vitamin E against cyclosporine A?induced oxidative stress and hepatotoxicity in rats. Hepatology Research. 2008 Apr;38(4):385-92.
10. Wu JC, Tsai ML, Lai CS, Wang YJ, Ho CT, Pan MH. Chemopreventative effects of tetrahydrocurcumin on human diseases. Food & function. 2014;5(1):12-7.
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of immunological methods. 1983 Dec 16;65(1-2):55-63.
12. Park HJ, Shin DH, Chung WJ, Leem K, Yoon SH, Hong MS, Chung JH, Bae JH, Hwang JS. Epigallocatechin gallate reduces hypoxia-induced apoptosis in human hepatoma cells. Life sciences. 2006 May 8;78(24):2826-32.
13. Niehaus Jr WG, Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. European journal of biochemistry. 1968 Oct;6(1):126-30.
14. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase.
15. Aebi H. [13] Catalase in vitro. InMethods in enzymology 1984 Jan 1 (Vol. 105, pp. 121-126). Academic press.
16. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra W. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973 Feb 9;179(4073):588-90.
17. Ellman GL. Tissue sulfhydryl groups. Archives of biochemistry and biophysics. 1959 May 1;82(1):70-7.
18. Mathur A, Hong Y, Kemp BK, Barrientos AA, Erusalimsky JD. Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovascular research. 2000 Apr 1;46(1):126-38.
19. Xiong W, Hua J, Liu Z, Cai W, Bai Y, Zhan Q, Lai W, Zeng Q, Ren H, Xu D. PTEN induced putative kinase 1 (PINK1) alleviates angiotensin II-induced cardiac injury by ameliorating mitochondrial dysfunction. International Journal of Cardiology. 2018 Sep 1;266:198-205.
20. Tanaka A, Youle RJ. A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis. Molecular cell. 2008 Feb 29;29(4):409-10.
21. Su H, Pistolozzi M, Shi X, Sun X, Tan W. Alterations in NO/ROS ratio and expression of Trx1 and Prdx2 in isoproterenol-induced cardiac hypertrophy. Acta Biochimica et Biophysica Sinica. 2017 Nov;49(11):1022-8.
22. Sivasangari S, Asaikumar L, Vennila L, Vijayakumar N. Preventive effect of arbutin on isoproterenol-induced oxidative stress, mitochondrial damage and apoptosis in H9c2 cells. International Journal of Nutrition, Pharmacology, Neurological Diseases. 2019 Jul 1;9(3):97-104.
23. Fiskum G, Rosenthal RE, Vereczki V, Martin E, Hoffman GE, Chinopoulos C, Kowaltowski A. Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress. Journal of bioenergetics and biomembranes. 2004 Aug;36:347-52.
24. Li K, Zhai M, Jiang L, Song F, Zhang B, Li J, Li H, Li B, Xia L, Xu L, Cao Y. Tetrahydrocurcumin ameliorates diabetic cardiomyopathy by attenuating high glucose-induced oxidative stress and fibrosis via activating the SIRT1 pathway. Oxidative medicine and cellular longevity. 2019 Oct;2019.
25. Atsumi T, Tonosaki K, Fujisawa S. Comparative cytotoxicity and ROS generation by curcumin and tetrahydrocurcumin following visible-light irradiation or treatment with horseradish peroxidase. Anticancer research. 2007 Jan 1;27(1A):363-71.
26. Singal PK, Beamish RE, Dhalla NS. Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. InMyocardial injury 1983 Jan 1 (pp. 391-401). Boston, MA: Springer US.
27. Noronha-Dutra AA, Steen EM, Woolf N. The correlation between catecholamine and lipid peroxidation induced damage in heart cells. InAdult heart muscle cells: Isolation, properties and applications 1984 (pp. 133-136). Steinkopff.